Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 20.00 (3.922%)
Market Cap: £85.31m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Acquisition

30 Mar 2012 07:00

Anpario plc ("Anpario", the "Company" or the "Group")

Acquisition of Meriden Animal Health Limited

Highlights

Acquisition of Meriden Animal Health Limited ("Meriden") for up to £4.125 million Meriden's 2011 sales and adjusted profit before interest and tax were £5.35 million and £740,000 respectively Expected to be immediately earnings enhancing Deal increases Anpario's global market share and significantly strengthens its position in China Consideration to be met from the Company's existing cash resources

Anpario plc, one of the leading suppliers of natural high performance feed additives to enhance health, growth and sustainability in global agriculture and aquaculture markets, is pleased to announce the acquisition of Meriden Animal Health Limited for a total consideration of up to £4.125 million.

The acquisition of Meriden brings another strong trading brand to the Anpario Group, broadening its product technology and increasing Anpario's global market share in the feed additive sector.

Meriden based in Bedfordshire in the United Kingdom, supplies the global agriculture and aquaculture markets with natural animal feed additive products. Meriden's Orego-Stim range of products, using essential oils, is the leading brand in its field and is marketed across 60 countries worldwide, with the majority of sales being outside the United Kingdom

Meriden's sales for the 12 months to December 2011 were £5.35 million and adjusted profit before interest and tax was £740,000. Net assets acquired will be at least £1.644 million, the majority being working capital, including cash in excess of £400,000. The acquisition is expected to be immediately earnings enhancing to the Group as a whole.

Meriden has ten full time staff including a technical support team based in a representative office in Malaysia. The majority of production is outsourced to a third party manufacturer based in the United Kingdom. Meriden typically supplies through distributors in the local territories except Australia where the company has a joint venture company.

Meriden has a close and important partnership with its China operation with sales accounting for 26% of Meriden's total sales during 2011. The China business has been growing well and Anpario intends to give further support to this relationship to capitalise on the vast potential of China's agriculture market.

In line with Anpario's strategy, Meriden will be run as a separate business enabling the team to focus on selling and marketing high quality feed additive products around the world. Joining Anpario means Meriden's management team will gain additional support and can benefit from working together with Anpario's research and development resource to develop new and innovative products for sale under the Meriden brand.

The two shareholders and founders, namely, Stephen Harris, Managing Director, and Pamela McLaren, Company Secretary, are to remain with the business in their existing roles and will continue to develop the Meriden business further.

The price payable for Meriden is on a debt free basis but will include estimated excess cash of £400,000. An initial payment of £3.0 million in cash on completion has been made from existing cash resources. The remaining £1.125 million is payable over the next two years, dependent on Meriden achieving certain performance criteria, and of this, £125,000 is to be satisfied by the issue of ordinary shares of Anpario to Meriden's shareholders. Subsequent to the completion of this acquisition, Anpario's cash balances will be in excess of £2.5 million.

The Company expects to announce its results for the year ended 31 December 2011 on 26 April 2012.

Richard Edwards, Executive Vice Chairman of Anpario, commented:

"Meriden Animal Health is a quality business with strong brand recognition for developing 100% natural feed additives. This acquisition increases our global market share in animal feed additives which is benefiting as the agriculture industry looks to use natural based solutions to promote the health and growth of animals for meat consumption.

Meriden's significant presence in China increases our involvement in the world's biggest producer of poultry and pig meat and reinforces our strategy to build more significant positions in emerging agriculture and aquaculture markets. We are delighted to welcome the Meriden team and very much look forward to working with them in achieving continued success with the business."

Enquiries:

Anpario plcRichard Edwards, Executive Vice Chairman +44 (0)7776 417129Karen Prior, Group Finance Director +44 (0)1909 537380

FinnCap +44 (0)20 7600 1658Matthew Robinson / Henrik Persson - Corporate FinanceStephen Norcross - Corporate Broking

Copyright Business Wire 2012

Date   Source Headline
4th Nov 20082:00 pmRNSDirector/PDMR Shareholding
27th Oct 20082:00 pmRNSDividend Declaration
23rd Oct 20082:57 pmRNSBEE restructuring agreement
23rd Oct 20087:00 amRNSAnglo Platinum Quarterly Review and Prod Report
23rd Sep 200812:00 pmRNSDirectorate Change
20th Aug 20089:42 amRNSDividend Declaration
1st Aug 20084:30 pmRNSDirector/PDMR Shareholding
28th Jul 20088:00 amRNSInterim Results
28th Jul 20088:00 amRNSAnglo Platinum Limited
23rd Jul 200812:32 pmRNSBlocklisting Interim Review
18th Jul 20082:32 pmRNSBlocklisting Interim Review
17th Jul 200812:15 pmRNSBlocklisting Interim Review
15th Jul 200811:19 amRNSBlocklisting Interim Review
14th Jul 200811:36 amRNSTrading Statement
2nd Jul 20083:07 pmRNSDirectorate Change
13th May 20089:34 amRNSDirectorate Change
13th May 20089:30 amRNSAnglo Platinum CEO
30th Apr 20082:31 pmRNSDividend Declaration
29th Apr 200811:25 amRNSNew order mining rights
29th Apr 200811:03 amRNSMining Rights Conversions
29th Apr 20087:00 amRNSFirst Quarter Review
2nd Apr 20087:00 amRNSFinal Results
11th Mar 20089:43 amRNSDividend conversion rate
10th Mar 20081:04 pmRNSRevised Conversion Price
7th Mar 20081:54 pmRNSDirector/PDMR Shareholding
7th Mar 20089:35 amRNSEmployee Share Scheme
15th Feb 20089:18 amRNSSmelter Shutdown
11th Feb 20087:00 amRNSFinal Results
11th Feb 20087:00 amRNSFinal Results
11th Feb 20087:00 amRNSAnglo Platinum
31st Jan 20089:50 amRNSPlatinum Transaction
31st Jan 20089:27 amRNSJoint Transaction
25th Jan 20085:38 pmRNSEnergy Supply Talks
23rd Jan 20082:24 pmRNSInterruption: Mine Production
23rd Jan 200811:07 amRNSDirectorate Change
17th Jan 20089:57 amRNSBlocklisting Interim Review
11th Jan 200812:16 pmRNSBlock listing application
16th Nov 20072:00 pmRNSAnglo Platinum Announcement
16th Nov 20071:56 pmRNSReduction in target
7th Nov 200710:12 amRNSProposed Transactions
2nd Nov 20072:00 pmRNSDirectorate Change
26th Oct 20073:02 pmRNSDividend Declaration
11th Oct 20071:00 pmRNSDirectorate Change
1st Oct 20073:03 pmRNSDirector/PDMR Shareholding
25th Sep 20077:01 amRNSInterim Results
4th Sep 20077:01 amRNSNotification
24th Aug 20073:23 pmRNSWage negotiations
22nd Aug 20079:09 amRNSDividend Conversion Rate
6th Aug 20074:13 pmRNSDirector/PDMR Shareholding
1st Aug 20077:02 amRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.